“Choosing which claims to make,” an advertiser “affects the amount of substantiation required. A structure function claim, supports digestive health, may require a different level of substantiation than if you choose to make the claim prevents diarrhea,” says FTC attorney Christine DeLorme.

Trade group ask FTC to withdraw notices, arguing it is attempting to impose substantiation standard prohibited under FDA regulations for supplement manufacturing and marketing and are inconsistent with its own as well as FDA guidance

“The defendants’ argument rests on a misunderstanding of the basis for the contempt judgment” which were “imposed because the defendants violated the injunction,” says three-judge 11^th Circuit panel.

“We are concerned that these changes could divert resources, funding, and attention from the supplement market at a time when it is needed more than ever,” Democrats Dick Durbin and Richard Blumenthal says in letter to FDA.

Legislation to significantly reform regulation of medicines and medical devices in New Zealand passed by parliament and will soon become law, but pharma and medtech industries have reservations about some provisions.

Market's direction depends on different influences, according to witnesses testifying at recent House hearing looking at FDA’s position on using hemp ingredients in food and dietary supplements. Rising costs and plummeting prices hit marketers as acreage for hemp and amount harvested shrink.

France's Pierre Fabre is enhancing its presence in the women's health market by taking a stake in dietary supplements and cosmetics firm MiYé.

A partnership with Swiss functional ingredients supplier Phytonet AG brings UK prebiotic specialist Clasado 14 steps closer to global coverage for Bimuno GOS. 

Cipla has signaled its commitment to expanding its OTC offering with the acquisition of South Africa's Actor Pharma and its diversified consumer health portfolio.

Valbiotis and Nestlé Health Science plan to launch in 2024 a dietary supplement targeted at sufferers of prediabetes and type-2 diabetes following positive results from a recent study which showed the product's efficacy on key markers of glucose metabolism.

“Choosing which claims to make,” an advertiser “affects the amount of substantiation required. A structure function claim, supports digestive health, may require a different level of substantiation than if you choose to make the claim prevents diarrhea,” says FTC attorney Christine DeLorme.

France's Pierre Fabre is enhancing its presence in the women's health market by taking a stake in dietary supplements and cosmetics firm MiYé.

To counteract falling sales due to weaker immunity supplement demand post-pandemic, ingredients firm DSM-Firmenich is investing in innovation in the increasingly popular women's health and postbiotics product categories. 

Australian heritage dietary supplements brand Swisse achieved a significant sales milestone in the first half of 2023 reflecting growing demand for its products, particularly in China.

Germany's Dermapharm said strong global demand for dietary supplements, in combination with its acquisition of herbals specialist Arkopharma, had helped drive up sales in the first half of 2023.

Trade group ask FTC to withdraw notices, arguing it is attempting to impose substantiation standard prohibited under FDA regulations for supplement manufacturing and marketing and are inconsistent with its own as well as FDA guidance

“The defendants’ argument rests on a misunderstanding of the basis for the contempt judgment” which were “imposed because the defendants violated the injunction,” says three-judge 11^th Circuit panel.

“AMG decision had a dramatic effect on the ability of the FTC to get money in federal court. That said, there are still a lot of ways for the FTC to get money when they bring law enforcement actions,” advertising regulation attorney Daniel Kaufman.

Valbiotis and Nestlé Health Science plan to launch in 2024 a dietary supplement targeted at sufferers of prediabetes and type-2 diabetes following positive results from a recent study which showed the product's efficacy on key markers of glucose metabolism.

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

London-based start-up Phizz markets in the UK's busy wellness category effervescent products that it claims effectively hydrate while also providing essential vitamins and minerals.

In this special podcast episode, we speak to PAGB CEO Michelle Riddalls about her role as an OTC Marketing Awards judge and what makes a good entry in her extensive experience. Having spent two decades working in some of the world's largest OTC companies, and now heading up the UK’s OTC industry association which plays an important role in reviewing members' marketing campaigns before they go live, Riddalls is well placed to offer advice to companies working on their entries. Making submissions UK-specific, data-driven but also inclusive of all the creativity that teams bring to a launch or campaign are some of the pointers Riddalls shares with us. Friday 1 September is the entry deadline for the 2023 Awards, which take place at the Royal Lancaster London on Thursday 23 November. If you are interested in entering, head over to Citeline’s 2023 UK OTC Marketing Awards website.

All you need to know about the upcoming OTC Marketing Awards ahead of the 1 September entry deadline.

“MacuHealth believes challenged claims are thoroughly supported by the multitude of peer reviewed, published scientific studies” but NAD review on Vision Elements challenge finds firm’s research doesn’t support its claims.

“Choosing which claims to make,” an advertiser “affects the amount of substantiation required. A structure function claim, supports digestive health, may require a different level of substantiation than if you choose to make the claim prevents diarrhea,” says FTC attorney Christine DeLorme.

Trade group ask FTC to withdraw notices, arguing it is attempting to impose substantiation standard prohibited under FDA regulations for supplement manufacturing and marketing and are inconsistent with its own as well as FDA guidance